Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study
Anticancer Research · 2025-10 · 45 (10) · 4281-4293
DOI: 10.21873/anticanres.17779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 26.09.2025. Verfasst von Shoma Barat und 4 weiteren Autor:innen. Beteiligte Einrichtung: St George and Sutherland Clinical School, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Cytoreduction Surgical Procedures, Ovarian Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St George and Sutherland Clinical School, University of New South Wales, Sydney, Australia.
- Department of Surgery, Peritonectomy Unit, St George Hospital, Sydney, Australia.
- St George and Sutherland Clinical School, University of New South Wales, Sydney, Australia; david.morris@unsw.edu.au.
Zitieren
APA
Barat, S., Ahmadi, N., Wijayawardana, R., Liauw, W., & Morris, D. (2025). Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study. Anticancer Research, 45(10), 4281-4293. https://doi.org/10.21873/anticanres.17779
Vancouver
Barat S, Ahmadi N, Wijayawardana R, Liauw W, Morris D. Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study. Anticancer Research. 2025;45(10):4281-4293. doi:10.21873/anticanres.17779
BibTeX
@article{Barat2025,
author = {Barat, Shoma and Ahmadi, Nima and Wijayawardana, Ruwanthi and Liauw, Winston and Morris, David},
title = {Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {10},
pages = {4281--4293},
doi = {10.21873/anticanres.17779}
}
EUVIMED